Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples